Axon Medical Technologies, LLC Chief Science Officer Michael Zarreii shared his excitement Thursday following Pennsylvania Governor Tom Wolf’s signing of House Bill 1082. “This is a great day for Pennsylvanians at risk of memory loss and neurodegenerative disease and their families,” Zarreii said. “I am pleased that the governor recognizes and supports efforts for the […]
Author Archives: Beth McCoy
Physicians treating patients concerned about memory loss now have access to a new, non-invasive medical device that administers cognitive assessments anywhere with an internet connection. The FDA-registered headgear device objectively measures cognitive health to help physicians make more accurate and timely observations about memory loss. The Intellig-EYES™ tool changes the cognitive assessment landscape by detecting […]
A new, non-invasive enhanced cognitive assessment test (ECAT) platform is now available for treating patients at risk of neurodegenerative disease. The tool uses both objective and subjective tests to evaluate cognitive ability. Central to the ECAT platform is the objective measurement of cranial nerves II, III, IV, and VI through eye movement to help provide […]
Adults experiencing memory lapses now have access to a new and convenient, technologically-advanced, cognitive assessment test that allows early intervention and treatment for those at risk of memory loss. “Many adults experience forgetfulness or absentmindedness during everyday activities—misplacing car keys or the name of a television program—and fear they are experiencing memory loss due to […]